Annika B.
- Country
- Sweden
- Department
- Medical Unit Upper Abdominal
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Hepatobiliary Disorders
The investigator specializes in the treatment and research of primary sclerosing cholangitis (PSC), a progressive liver condition affecting the bile ducts. Their work focuses on evaluating innovative therapeutic approaches for managing this challenging disease.
- Bile duct inflammation and scarring
- Liver disease progression
- Biliary tract complications
The research encompasses investigation of both conventional and novel treatment modalities for PSC management.
Therapeutic Innovation
This investigator explores various therapeutic agents including norucholic acid and simvastatin for PSC treatment. Their research aims to identify effective interventions for improving patient outcomes.
- Novel therapeutic compounds
- Drug safety assessment
- Treatment tolerability studies
The focus includes evaluation of both emerging and established medications for treating chronic liver conditions.
Clinical Outcomes
The investigator's research examines critical clinical endpoints in liver disease management, particularly focusing on survival rates and prevention of serious complications.
- Bile duct cancer prevention
- Variceal bleeding management
- Transplantation timing
Their work addresses the prevention and management of severe complications associated with PSC.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.